Things Have Turned Ugly

 
Things have turned ugly in China, which leads us to turn very defensive. Four days ago, hoping to get the volatility of Chinese stock markets under control, the China Securities Regulatory Commission (CSRC), the Chinese equivalent of the SEC, instituted a circuit breaker mechanism that would allow them to shut down trading if declines reached a trip-wire level. That circuit breaker has been used twice now, including this morning and the reaction has been so negative that the CSRC announced on Weibo today that the circuit breaker mechanism was being suspended.

Monday’s global equities selloff was partly the result of the implosion in Chinese markets, which was, in turn, partly the result of negative economic news about the Chinese economy. Today’s meltdown in Chinese markets is having a similar effect. And the Chinese central bank’s devaluations of the yuan, which are an attempt to shore up the Chinese export economy, is adding to the chaos by raising the specter of capital flight from China. The devaluations also suggest that the government’s stimulus program isn’t getting any traction, and that’s a little chilling in itself.

But in a larger sense, knowing why a market move takes place is just an intellectual game. The important thing is knowing how to react, and that’s a matter of making decisions about the individual stocks in your portfolio.

Today, as always, we are reviewing our holdings and making those decisions about our stocks. You should be doing the same with all the growth stocks in your portfolio, making individual decisions about each of them separately. Don’t take a shovel to your portfolio when a pair of tweezers will do. But don’t fail to take action. Markets love a stationary target.

The iShares MSCI Emerging Markets ETF (EEM), which tried to bounce in mid-December, has been correcting hard, and is now nearly back to its August Meltdown lows. PowerShares Golden Dragon (PGJ), which rallied nicely right through December 24, has rolled over, dropping below its 25- and 50-day moving averages on heavy trading volume. Thus, our Emerging Markets Timer’s red light is joined by a similar signal from the ETF that tracks Chinese ADRs. We are adjusting the portfolio accordingly.

The major indexes started the day on the downside and got weaker as the day went on. The selloff was broad, and at the close, the Dow was down 391 points (-2.3%), the S&P 500 down 47 points (-2.4%), and the Nasdaq lower by 146 points (3.0%). The iShares MSCI Emerging Markets ETF (EEM) fell 95 cents (-1.0%).


This is an excerpt from Cabot Emerging Markets Investor, which seeks to capitalize on the enormous potential in emerging market countries. Chief Analyst Paul Goodwin has been a researcher and writer for over 30 years and a member of the Cabot investment team since 2005.

Subscriber comments on Cabot Emerging Markets Investor


Paul Goodwin can be found on Google Plus.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >